CONTACTStaffCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The National Institutes of Health, the Bill and Melinda Gates Foundation, and the Centers for Disease Control and Prevention this week announced funding of three separate human trials of the antiretroviral drug Viread to prevent HIV infections, The Wall Street Journal reports. The drug, approved for use as part of combination therapy to treat HIV infection, has been shown in early tests to prevent HIV infection when taken regularly as pre-exposure prophylaxis. The human trials will include studies of sexually active gay and bisexual men in San Francisco and Atlanta, sex workers in Cambodia, and HIV-negative volunteers in four African nations. The Gates Foundation has provided $6.5 million for the African study, the NIH is supporting the Cambodian trial with a $2.1 million grant, and the study of sexually active gay men is funded by a $3.5 million CDC grant. Some at-risk people are already taking the anti-HIV drug to help prevent HIV infection, the Journal reports, which draws both support and caution from physicians. "I believe in being ahead of the curve. But if we're wrong, the results could be devastating," said Howard Grossman, a New York AIDS specialist. Viread has such side effects as kidney and bone toxicity. But health experts also worry that those currently taking the anti-HIV medication to prevent infection could stop using condoms or increase their sexual risk-taking because they believe the medication will shield them from HIV infection, which has not yet been proven. Officials at Gilead Sciences, the maker of Viread, are optimistic that the trials will show that the medication lowers the chances of HIV infection and plan to examine ways to boost production of the drug to handle the "tremendous number of people who would require Viread," said company vice president of clinical research James Rooney.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Meet all 37 of the queer women in this season's WNBA
April 17 2024 11:24 AM
Here are the 15 gayest travel destinations in the world: report
March 26 2024 9:23 AM
21+ steamy photos of Scotland’s finest gay men in Elska Glasgow
February 01 2024 10:07 PM
More Than 50 of Our Favorite LGBTQ+ Moms
May 12 2024 11:44 AM
Conjoined twins Lori Schappell and trans man George Schappell dead at 62
April 27 2024 6:13 PM
Latest Stories
Joe Biden sends queer lawmakers & LGBTQ+ allies to Paris Olympics
July 24 2024 12:08 PM
Kamala Harris rides wave of Democratic energy at kickoff event in Wisconsin
July 23 2024 3:36 PM
'Devastated:' A six-week abortion ban will go into effect in Iowa next week
July 23 2024 2:28 PM
Four hours, 44,000 Black women, and one Zoom call
July 23 2024 2:17 PM